Literature DB >> 8549732

Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain).

C Amela1, I Pachón, R Bueno, C de Miguel, F Martinez-Navarro.   

Abstract

Hepatitis A is an infection transmitted by the fecal-oral route. Endemicity within a specific country is directly related to sanitation and hygienic standards, while being inversely related to socioeconomic conditions. We studied how the process of urbanization witnessed in Madrid had influenced the transmission of hepatitis A infection. In the Madrid Autonomous Region, this process first began in the early sixties and was not brought to a close until the late seventies. Catalytic models were used to estimate the annual infection rate, lambda, on the basis of seroprevalence data stratified by age. A cohort effect related to a fall-off in infancy-related hepatitis A virus (HAV) is to be observed in the results for the last few years. The model permits four birth cohort-based groups to be differentiated by lambda: individuals born pre-1960, lambda = 0.082 (95% CI 0.095-0.070); those born in the early sixties, lambda = 0.052 (95% CI 0.060-0.042); whose members were born in the late sixties, lambda = 0.033 (95% CI 0.041-0.025); and those born in the late seventies, lambda = 0.017 (95% CI 0.020-0.013). The first group includes those born before the urbanization process had started. The second and third groups coincide with the development stage of that process, hence exhibiting transitional rates. The fourth group reflects the process in its consolidation stage. This reduction in the transmission of infection has changed the manner of presentation, so that while isolated cases or small outbreaks tend to be more common nowadays, occasionally epidemics may evolve explosively. The average age at presentation has risen and the likelihood of symptomatic infection is higher.

Entities:  

Mesh:

Year:  1995        PMID: 8549732     DOI: 10.1007/bf01719310

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  6 in total

1.  Sociodemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adults in Israel: implications for the new hepatitis A vaccines.

Authors:  M S Green; S Tsur; R Slepon
Journal:  Int J Epidemiol       Date:  1992-02       Impact factor: 7.196

2.  Relationship between prevalence of antibody to hepatitis A antigen and age: a cohort effect?

Authors:  I D Gust; N I Lehmann; C R Lucas
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

3.  Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys.

Authors:  D Schenzle; K Dietz; G G Frösner
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

4.  The estimation of age-related rates of infection from case notifications and serological data.

Authors:  B T Grenfell; R M Anderson
Journal:  J Hyg (Lond)       Date:  1985-10

5.  A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan.

Authors:  H Ikematsu; S Kashiwagi; J Hayashi; H Nomura; W Kajiyama; S Tani; Y Uragari; M Goto
Journal:  Am J Epidemiol       Date:  1987-07       Impact factor: 4.897

6.  Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups.

Authors:  G G Frösner; G Papaevangelou; R Bütler; S Iwarson; A Lindholm; A Couroucé-Pauty; H Haas; F Deinhardt
Journal:  Am J Epidemiol       Date:  1979-07       Impact factor: 4.897

  6 in total
  7 in total

Review 1.  Considerations of HAV vaccine in India.

Authors:  P Mathur; N K Arora
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

2.  A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Authors:  Donghun Lee; Moran Ki; Anna Lee; Kyoung Ryul Lee; Hee Bong Park; Chang Sub Kim; Bo Young Yoon; Jong Hyun Kim; Young Sok Lee; Sook Hyang Jeong
Journal:  Korean J Hepatol       Date:  2011-03

3.  Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004.

Authors:  G Cilla; E Pérez-Trallero; J Artieda; E Serrano-Bengoechea; M Montes; D Vicente
Journal:  Epidemiol Infect       Date:  2006-07-19       Impact factor: 2.451

4.  Is there a change in cytomegalovirus seroepidemiology in Spain?

Authors:  F de Ory; R Ramírez; L García Comas; P León; M J Sagües; J C Sanz
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Hepatitis a in developed country, the result should interpret carefully.

Authors:  Seyed-Moayed Alavian
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

6.  HAV Immunity in Iranian Medical Students.

Authors:  Seyyed Javad Hosseini Shokouh; Alireza Dadashi; Mohamad Abiri; Iraj Zohrevand; Ahad Eshraghian; Alireza Khoshdel; Behnam Heidari; Shayan Khoshkish
Journal:  Hepat Mon       Date:  2015-03-31       Impact factor: 0.660

7.  Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.

Authors:  Kyung-Ah Kim; Anna Lee; Moran Ki; Sook-Hyang Jeong
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.